Chiral Separation of Deprenyl-N-Oxide Isomers by Capillary Electrophoresis Using Various Cyclodextrin Derivatives

Journal of Chromatographic Science

Volumn 42, Issue 1, 2004, Pages 21-26

  Tábi, Tamás ^a   Halász, Attila Sándor ^a   Pálfi, Melinda ^a   Magyar, Kálmán ^a,b   Szöko, Éva ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CARBOXYETHYL BETA CYCLODEXTRIN; CYCLODEXTRIN DERIVATIVE; DEPRENYL N OXIDE; DRUG METABOLITE; HEPTAKIS(2,6 O DIMETHYL) BETA CYCLODEXTRIN; SELEGILINE; UNCLASSIFIED DRUG;

ARTICLE; CAPILLARY ELECTROPHORESIS; CHIRALITY; DRUG ANALYSIS; ENANTIOMER; ENANTIOSELECTIVITY; HYDROGEN BOND; HYDROPHILICITY; ISOMER; SEPARATION TECHNIQUE;

EID: 0348228010     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/42.1.21     Document Type: Article

References (28)

1. M.R. Hadley, P. Camilleri, and A.J. Hutt. Enantiospecific analysis by capillary electrophoresis: Applications in drug metabolism and pharmacokinetics. Electrophoresis 21: 1953-76 (2000).
2. G. Blaschke and B. Chankvetadze. Enantiomer separation of drugs by capillary electromigration techniques. J. Chromatogr. A 875: 3-25 (2000).
3. S. Zaugg and W. Thormann. Enatioselective determination of drugs in body fluids by capillary electrophoresis. J. Chromatogr. A 875: 27-41 (2000).
4. A. Amini. Recent developments in chiral capillary electrophoresis and applications of thistechnique to pharmaceutical and biomedical analysis. Electrophoresis 22: 3107-30 (2001).
5. B. Chankvetadze and G. Blaschke. Enantioseparations in capillary electromigration techniques: recent developments and future trends. J. Chromatogr. A 906: 309-63 (2001).
6. J. Szejtli. Cyclodextrins and Their Inclusion Complexes. Akadémiai Kiadó, Budapest, Hungary, 1982.
7. S. Fanali. Enantioselective determination by capillary electrophoresis with cyclodextrins as chiral selectors. J. Chromatogr. A 875: 89-122 (2000).
8. B. Chankvetadze and G. Blaschke. Selector-selectand interactions in chiral capillary electrophoresis. Electrophoresis 20: 2592-2604 (1999).
9. J. Knoll, Z. Ecseri, K. Kelemen, J. Nievel, and B. Knoll. Phenyl-isopropyl-methyl-propinylamine (E-250), a new spectrum psychic energizer. Arch. Int. Pharmacodyn. Ther. 155: 154-64 (1965).
10. K. Magyar, E.S. Vizi, Z. Ecseri, and J. Knoll. Comparative pharmacological analysis of the optical isomers of phenyl-isopropyl-methyl-propinylamine (E-250). Acta Physiol. Hung. 32: 377-87 (1967).
11. D. Haberle, É. Szöko, A.S. Halász, and K. Magyar. The effect of low oral doses of (-)-deprenyl and its metabolites on DSP-4 toxicity. J. Neural Transm. 108: 1239-47 (2001).
12. K. Magyar, B. Szende, J. Lengyel, and K. Tekes. The pharmacology of B-type selective monoamine oxidase inhibitors; milestones in (-)-deprenyl research. J. Neural Transm. Suppl. 48S: 29-43 (1996).
13. W.G. Tatton, R.M.E. Chalmers-Redman, W.Y.H. Yu, J. Waida, and N.A. Tatton. Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription. J. Neural Transm. Suppl. 49S: 245-68 (1997).
14. K. Magyar, B. Szende, J. Lengyel, H. Tarczali, and I. Szatmáry. The neuroprotective and neuronal rescue effects of (-)-deprenyl. J. Neural Transm. Suppl. 52S: 109-23 (1998).
15. B. Szende, Gy. Bököny, J. Bocsi, Gy. Kéri, F. Timár, and K. Magyar. Anti-apoptotic and apoptotic action of (-) -deprenyl and its metabolites. J. Neural Transm. 108: 25-33 (2001).
16. R.F. Wu and Y. Ichikawa. Inhibition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolic activity of porcine FAD-containing monooxygenase by selective monoamine oxidase-B inhibitors. FEBS Lett. 358: 245-68 (1995).
17. T. Tábi, K. Magyar, and É. Szöko. Chiral characterization of deprenyl-N-oxide and other deprenyl metabolites by capillary electrophoresis using dual cyclodextrin system in rat urine. Electrophoresis 24: 2665-73 (2003).
18. M. Katagi, M. Tatsuno, A. Miki, M. Nishikawa, K. Nakajima, and H. Tsuchihasi. Simultaneous determination of selegiline-N-oxide, a new indicator for selegiline administration, and other metabolites in urine by high-performance liquid chromatography-electrospray ionization mass spectroscopy. J. Chromatogr. B 759: 125-33 (2001).
19. M. Katagi, M. Tatsuno, H. Tatsuno, A. Miki, T. Kamata, K. Nakajima, M. Nishikawa, and H. Tsuchihasi. Urinary excretion of selegiline N-oxide, a new indicator for selegiline administration in man. Xenobiotica 9: 823-31 (2002).
20. M.R. Hadley, S.D. Gabriac, and S.J. Hutt. Resolution of enantiomeric N-oxides by capillary electrophoresis using cyclodextrins as chiral selectors. Chirality 11: 409-15 (1999).
21. É. Szöko and K. Magyar. Chiral separation of deprenyl and its major metabolites using cyclodextrin-modified capillary zone electrophoresis. J. Chromatogr. A 709: 157-62 (1995).
22. E. Szöko, J. Gyimesi, L. Barcza, and K. Magyar. Determination of binding constants and the influence of methanol on the separation of drug enantiomers in cyclodextrin modified capillary electrophoresis. J. Chromatogr. A 745: 181-87 (1996).
23. A. Guttman. Novel separation scheme for capillary electrophoresis of enantiomers. Electrophoresis 16: 1900-1905 (1995).
24. A. Guttman. Handbook of Capillary Electrophoresis, 2nd ed. J.P. Landers, Ed. CRC Press, Boca Raton, FL, 1997, pp. 75-100.
25. B. Koppenhoefer, X. Zhu, A. Jakob, S. Wuerthner, and B. Lin. Separation of drug enantiomers by capillary electrophoresis in the presence of neutral cyclodextrins. J. Chromatogr. A 875: 135-61 (2000).
26. S.A.C. Wren and R.C. Rowe. Theoretical aspects of chiral separation in capillary electrophoresis. I. Initial evaluation of a model. J. Chromatogr. 603: 235-41 (1992).
27. S.A.C. Wren and R.C. Rowe. Theoretical aspects of chiral separation in capillary electrophoresis. III. Application to beta-blockers. J. Chromatogr. 635: 113-18 (1993).
28. M. Fillet, I. Bechet, Ph. Hubert, and J. Crommen. Resolution improvement by use of carboxymethyl-b-cyclodextrin as chiral additive for the enantiomeric separation of basic drugs by capillary electrophoresis. J. Pharm. Biomed. Anal. 14: 1107-14 (1996).